SGLT2 inhibitors reduce the risk of hospitalization for heart failure and amputation rate compared with incretin-based therapy in patients with diabetic foot disease: A nationwide population-based study
Published: 13 November 2023| Version 1 | DOI: 10.17632/jdv9bjtnxw.1
Contributor:
Yi-Hsuan LinDescription
supplementary table and figures
Files
Steps to reproduce
from NHIRD
Categories
Diabetes, Heart Failure, Amputation